NCT02380157 - Blood Pressure Regulation - Role of Potassium | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Blood PressureHypertension

Interventions

DRUG

Kaleorid, 750mg (trade name), Potassium chloride (active substance)

4 weeks treatment with Kaleorid, 750mg, 3 tablets 3 times daily.

DRUG

Placebo

4 weeks treatment with Placebo tablets, 3 tablets 3 times daily.

Trial Locations (1)

Department of Clinical Physiology and Nuclear Medicine, Glostrup Hospital, University of Copenhagen, Glostrup, Copenhagen